A new study affirms that the 2009 H1N1 flu vaccine, developed to counter the flu pandemic , does not substantially put people at increased risk of Guillain-Barré syndrome, a disorder in which a person’s immune system damages nerves causing weakness and in some cases paralysis.
Read more:
Little Risk of Guillain-Barré with H1N1 Flu Vaccine